We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-0.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$34.1B
AUM Growth
-$1.11B
(-3.1%)
Cap. Flow
-$521M
Cap. Flow
% of AUM
-1.53%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
791
New
49
Increased
168
Reduced
395
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$73.6M |
| 2 |
Cisco
CSCO
|
+$63.8M |
| 3 |
ABB
ABB Ltd
ABB
|
+$60.9M |
| 4 |
Visa
V
|
+$59.5M |
| 5 |
Amazon
AMZN
|
+$59.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$288M |
| 2 |
ExxonMobil
XOM
|
+$65.3M |
| 3 |
Lowe's Companies
LOW
|
+$62.5M |
| 4 |
FRX
FOREST LABORATORIES INC
FRX
|
+$54.2M |
| 5 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$42.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.41% |
| 2 | Financials | 12.14% |
| 3 | Healthcare | 11.87% |
| 4 | Industrials | 7.92% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Interface
TILE
$2.22B
| $17M | 0.05% |
1,050,725
-27,792
| -3% | -$479K |
|
352
Insulet
PODD
$9.79B
| $16.8M | 0.05% |
456,413
-12,074
| -3% | -$441K |
|
|
ROSE
353
DELISTED
ROSETTA RESOURCES INC
ROSE
| $16.7M | 0.05% |
375,723
-14,774
| -4% | -$736K |
|
354
Omega Healthcare
OHI
$14.7B
| $16.7M | 0.05% |
488,690
-5,660
| -1% | -$208K |
|
355
MKS Inc
MKSI
$20.6B
| $16.7M | 0.05% |
+500,281
| New | +$16.4M |
|
|
MGAM
356
DELISTED
MULTIMEDIA GAMES HOLDING COMPANY INC COM STK (TX)
MGAM
| $16.7M | 0.05% |
+463,041
| New | +$13.9M |
|
357
MSCI
MSCI
$40.9B
| $16.6M | 0.05% |
353,340
+127,511
| +56% | +$5.9M |
|
358
Power Integrations
POWI
$3.61B
| $16.6M | 0.05% |
615,362
+66,588
| +12% | +$1.88M |
|
359
Cabot Corp
CBT
$4.52B
| $16.6M | 0.05% |
326,039
-1,344
| -0.4% | -$73.7K |
|
|
CKEC
360
DELISTED
Carmike Cinemas Inc
CKEC
| $16.5M | 0.05% |
533,958
-59,217
| -10% | -$1.95M |
|
|
EFOR
361
Everforth Inc
EFOR
$1.32B
| $16.5M | 0.05% |
615,171
-78,188
| -11% | -$2.42M |
|
362
Mid-America Apartment Communities
MAA
$15.7B
| $16.5M | 0.05% |
251,034
-29,038
| -10% | -$2.07M |
|
|
WCC
363
WESCO International
WCC
$17.7B
| $16.4M | 0.05% |
209,488
-10,101
| -5% | -$835K |
|
364
RH
RH
$3.71B
| $16.4M | 0.05% |
205,582
+16,978
| +9% | +$1.42M |
|
365
Primoris Services
PRIM
$4.45B
| $16.3M | 0.05% |
607,621
+31,858
| +6% | +$873K |
|
|
HSNI
366
DELISTED
HSN, Inc.
HSNI
| $16.3M | 0.05% |
265,323
-1,068
| -0.4% | -$62.8K |
|
367
Employers Holdings
EIG
$889M
| $16.2M | 0.05% |
842,090
-3,474
| -0.4% | -$72.3K |
|
368
Neurocrine Biosciences
NBIX
$16.6B
| $16.2M | 0.05% |
1,034,359
-23,874
| -2% | -$357K |
|
|
BPFH
369
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $16.2M | 0.05% |
1,304,451
-34,506
| -3% | -$435K |
|
|
THR
370
DELISTED
Thermon Group Holdings
THR
| $16.1M | 0.05% |
661,089
-17,479
| -3% | -$450K |
|
|
CBM
371
DELISTED
Cambrex Corporation
CBM
| $16.1M | 0.05% |
863,502
+70,664
| +9% | +$1.52M |
|
372
Healthcare Services Group
HCSG
$1.53B
| $16.1M | 0.05% |
563,034
+559,480
| +15,742% | +$15.6M |
|
373
John Wiley & Sons Class A
WLY
$2.66B
| $16.1M | 0.05% |
286,704
-1,193
| -0.4% | -$71K |
|
|
CMRX
374
DELISTED
Chimerix, Inc.
CMRX
| $16M | 0.05% |
577,724
-15,279
| -3% | -$371K |
|
375
Minerals Technologies
MTX
$2.34B
| $15.9M | 0.05% |
257,794
-1,059
| -0.4% | -$66K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q3 2014 Portfolio in Review
As of Q3 2014, Loomis, Sayles & Company held 791 positions worth $34.1B, down 3.1% from $35.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Loomis, Sayles & Company's Q3 2014 filing shows 49 new, 168 increased, 395 reduced and 78 closed positions. Its largest new stake was ABB Ltd: 2,657,098 shares worth $59.5M. The largest sale was Vertex Pharmaceuticals, an estimated $288M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Loomis, Sayles & Company's largest Q3 2014 buy was ABB Ltd: 2,657,098 shares worth $59.5M.
- Loomis, Sayles & Company added most to Royal Dutch Shell PLC ADS Class A in Q3 2014, an estimated $73.6M increase.
- Loomis, Sayles & Company's biggest Q3 2014 reduction was ExxonMobil, cutting an estimated $65.3M.
- Loomis, Sayles & Company fully exited Vertex Pharmaceuticals in Q3 2014, selling an estimated $288M.
- Loomis, Sayles & Company's ten largest holdings make up 24% of its $34.1B portfolio in Q3 2014.
- Loomis, Sayles & Company opened 49 new positions and closed 78 in Q3 2014.
- Loomis, Sayles & Company's portfolio value fell 3.1% quarter-over-quarter to $34.1B.
Based on Loomis, Sayles & Company's 13F filing for Q3 2014, filed 14 Nov 2014.